Literature DB >> 22092609

Rhodococcus equi: clinical manifestations, virulence, and immunity.

S Giguère1, N D Cohen, M Keith Chaffin, S A Hines, M K Hondalus, J F Prescott, N M Slovis.   

Abstract

Pneumonia is a major cause of disease and death in foals. Rhodococcus equi, a gram-positive facultative intracellular pathogen, is a common cause of pneumonia in foals. This article reviews the clinical manifestations of infection caused by R. equi in foals and summarizes current knowledge regarding mechanisms of virulence of, and immunity to, R. equi. A complementary consensus statement providing recommendations for the diagnosis, treatment, control, and prevention of infections caused by R. equi in foals can be found in the same issue of the Journal.
Copyright © 2011 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh：

Year:  2011        PMID： 22092609     DOI： 10.1111/j.1939-1676.2011.00804.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN： 0891-6640            Impact factor:   3.333


  39 in total

1.  Study of lysozyme resistance in Rhodococcus equi.

Authors:  Laurent Hébert; Pauline Bidaud; Didier Goux; Abdellah Benachour; Claire Laugier; Sandrine Petry
Journal:  Curr Microbiol       Date:  2013-10-30       Impact factor: 2.188

2.  Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi.

Authors:  Londa J Berghaus; Steeve Giguère; Kristen Guldbech; Eleanor Warner; Ukachi Ugorji; Roy D Berghaus
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

3.  Activity of clarithromycin or rifampin alone or in combination against experimental Rhodococcus equi infection in mice.

Authors:  Alexandra J Burton; Steeve Giguère; Londa J Berghaus; Mary K Hondalus
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

4.  VapA of Rhodococcus equi binds phosphatidic acid.

Authors:  Lindsay M Wright; Emily M Carpinone; Terry L Bennett; Mary K Hondalus; Vincent J Starai
Journal:  Mol Microbiol       Date:  2017-12-22       Impact factor: 3.501

5.  PNAG-specific equine IgG1 mediates significantly greater opsonization and killing of Prescottella equi (formerly Rhodococcus equi) than does IgG4/7.

Authors:  Joana N Rocha; Lawrence J Dangott; Waithaka Mwangi; Robert C Alaniz; Angela I Bordin; Colette Cywes-Bentley; Sara D Lawhon; Suresh D Pillai; Jocelyne M Bray; Gerald B Pier; Noah D Cohen
Journal:  Vaccine       Date:  2019-01-26       Impact factor: 3.641

6.  Failure of a VapA/CpG oligodeoxynucleotide vaccine to protect foals against experimental Rhocococcus equi pneumonia despite induction of VapA-specific antibody and interferon-γ response.

Authors:  Katharina L Lohmann; A Marianela Lopez; Stephen T Manning; Fernando J Marques; Robert Brownlie; Andrew L Allen; Anna E Sangster; George Mutwiri; Volker Gerdts; Andrew Potter; Hugh G G Townsend
Journal:  Can J Vet Res       Date:  2013-07       Impact factor: 1.310

7.  An Invertron-Like Linear Plasmid Mediates Intracellular Survival and Virulence in Bovine Isolates of Rhodococcus equi.

Authors:  Ana Valero-Rello; Alexia Hapeshi; Elisa Anastasi; Sonsiray Alvarez; Mariela Scortti; Wim G Meijer; Iain MacArthur; José A Vázquez-Boland
Journal:  Infect Immun       Date:  2015-04-20       Impact factor: 3.441

Review 8.  Epidemiology and Molecular Basis of Multidrug Resistance in Rhodococcus equi.

Authors:  Sonsiray Álvarez-Narváez; Laura Huber; Steeve Giguère; Kelsey A Hart; Roy D Berghaus; Susan Sanchez; Noah D Cohen
Journal:  Microbiol Mol Biol Rev       Date:  2021-04-14       Impact factor: 11.056

9.  Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi.

Authors:  Erdal Erol; Mariela Scortti; Jordan Fortner; Mukesh Patel; José A Vázquez-Boland
Journal:  J Clin Microbiol       Date:  2021-07-28       Impact factor: 5.948

10.  Bioactive Synthetic-Bioinformatic Natural Product Cyclic Peptides Inspired by Nonribosomal Peptide Synthetase Gene Clusters from the Human Microbiome.

Authors:  John Chu; Xavier Vila-Farres; Sean F Brady
Journal:  J Am Chem Soc       Date:  2019-09-27       Impact factor: 15.419
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.